The ruling, which limits federal agencies' power to interpret ambiguous laws, now leaves crucial legislation like the Mental Health Parity and Addiction Equity Act vulnerable to court challenges, potentially unraveling years of hard-won progress.
In this episode, we’re joined by Rabia Muqaddam, senior staff attorney at the Center for Reproductive Rights. Muqaddam discusses the Supreme Court's recent decision that preserved access to the abortion pill mifepristone.
The layout of your phlebotomy station can significantly impact efficiency. A well-thought-out setup ensures that every tool is within reach, minimizing unnecessary movement and reducing patient wait times.
The Supreme Court made several recent decisions that impact healthcare, including overturning the Chevron deference and upholding access to the abortion pill mifepristone.
Three upcoming Supreme Court decisions have the potential to radically change FDA regulation of medications. The cases, which involve “Chevron deference” and the abortion pill mifepristone, were discussed on a panel during the BIO conference in San Diego.
Though the case started small, it has gained national attention and more than a dozen states have submitted an amicus brief in support of the Health and Hospital Corporation that operates 78 nursing facilities across Indiana.
State bans would mean sensitive patient data, such as interactions with a telehealth provider to obtain abortion drugs, could be used against someone as a threat. One expert warned that the value of such data will "skyrocket."
Finding the best analytics tools for health care revenue management can revolutionize operational processes. Compare the leading software options to discover helpful team resources.
A D.C. appeals court has granted CareFirst's request to file an appeal with the Supreme Court. "[T]he Supreme Court has yet to examine the issue of standing in the context of a data breach case," the health insurer noted in its motion.
Anthem just doesn't want to give up. The insurer has filed a petition with the U.S. Supreme Court seeking review of the Cigna deal.
Also, out-of-pocket costs per hospitalization soar, AstraZeneca seeks to extend Crestor patent under the Orphan Drug Act and Virginia Mason's CEO decides to stay after all.
Also, CDC approves trial of experimental Zika vaccine, Circassia Pharmaceuticals' cat allergy treatment fails and AI helps reduce misdiagnosis of breast cancer.
This webinar will explore how a banking platform approach could be the resource for your company.
Plus, Humana basing executive bonuses on member health, CMS adding thousands of new ICD-10 codes and the CRISPR patent fight is heating up.
“Congress passed the Affordable Care Act to improve health insurance markets, not to destroy them,” wrote Chief Justice John Roberts.
In the wake of the Supreme Court's decision to uphold federal subsidies for health insurance under the Affordable Care Act, Pennsylvania no longer will be establishing its own, state-run exchange, Gov. Tom Wolf said Thursday.
President Obama's opinion about the Supreme Court taking on King v. Burwell is made clear.
Even people not getting subsidies could be indirectly affected by a Supreme Court ruling against the administration because of the likelihood the decision would roil the insurance risk pool.